Bone and fat cells share a common progenitor, stromal/mesenchymal stem cells (MSCs), that can differentiate into osteoblasts or adipocytes. Osteogenesis and adipogenesis of MSCs maintain homeostasis under physiological conditions. The disruption of this homeostasis leads to bone-related metabolic diseases. For instance, reduction in bone formation, which is usually accompanied by an increase in bone marrow adipogenesis, occurs with aging, immobility, or osteoporosis. Thus, it is crucial to gain an understanding of how osteogenic and adipogenic lineages of MSCs are regulated. Here, we present evidence that let-7 is a positive regulator of bone development. Using gain- and loss-of-function approaches, we demonstrate that let-7 markedly promotes osteogenesis and suppresses adipogenesis of MSCs in vitro. Moreover, let-7 could promote ectopic bone formation of MSCs in vivo. Subsequent studies further demonstrated that let-7's effects are mediated through the repression of high-mobility group AT-hook 2 (HMGA2) expression. RNAi depletion of HMGA2 could also enhance osteogenesis and repress adipogenesis. Overall, we found a novel role of let-7/HMGA2 axis in regulating the balance of osteogenesis and adipogenesis of MSCs. Thus, let-7 can be used as a novel therapeutic target for disorders that are associated with bone loss and adipocyte accumulation.
Get full access to this article
View all access options for this article.
References
1.
FinkT, RasmussenJG, EmmersenJ, PilgaardL, FahlmanA, BrunbergS, JosefssonJ, ArnemoJM, ZacharV, SwensonJE and FrobertO. (2011). Adipose-derived stem cells from the brown bear (Ursus arctos) spontaneously undergo chondrogenic and osteogenic differentiation in vitro. Stem Cell Res, 7:89–95.
2.
PhinneyDG and ProckopDJ. (2007). Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views. Stem Cells, 25:2896–2902.
3.
PittengerMF, MackayAM, BeckSC, JaiswalRK, DouglasR, MoscaJD, MoormanMA, SimonettiDW, CraigS and MarshakDR. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284:143–147.
4.
ProckopDJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276:71–74.
5.
TokuzawaY, YagiK, YamashitaY, NakachiY, NikaidoI, BonoH, NinomiyaY, Kanesaki-YatsukaY, AkitaM, et al. (2010). Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genet, 6:e1001019
6.
AmbrosV. (2004). The functions of animal microRNAs. Nature, 431:350–355.
7.
BartelDP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116:281–297.
8.
IveyKN and SrivastavaD. (2010). MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell, 7:36–41.
GerinI, BommerGT, McCoinCS, SousaKM, KrishnanV and MacDougaldOA. (2010). Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab, 299:E198–E206.
11.
HuR, LiuW, LiH, YangL, ChenC, XiaZY, GuoLJ, XieH, ZhouHD, WuXP and LuoXH. (2011). A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem, 286:12328–12339.
12.
ItohT, NozawaY and AkaoY. (2009). MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem, 284:19272–19279.
13.
KimSY, KimAY, LeeHW, SonYH, LeeGY, LeeJW, LeeYS and KimJB. (2010). miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun, 392:323–328.
14.
KimYJ, BaeSW, YuSS, BaeYC and JungJS. (2009). miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res, 24:816–825.
15.
LiZ, HassanMQ, JafferjiM, AqeilanRI, GarzonR, CroceCM, van WijnenAJ, SteinJL, SteinGS and LianJB. (2009). Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem, 284:15676–15684.
16.
LiZ, HassanMQ, VoliniaS, van WijnenAJ, SteinJL, CroceCM, LianJB and SteinGS. (2008). A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A, 105:13906–13911.
17.
LuziE, MariniF, SalaSC, TognariniI, GalliG and BrandiML. (2008). Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res, 23:287–295.
18.
MizunoY, YagiK, TokuzawaY, Kanesaki-YatsukaY, SudaT, KatagiriT, FukudaT, MaruyamaM, OkudaA, et al. (2008). miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun, 368:267–272.
19.
SunT, FuM, BookoutAL, KliewerSA and MangelsdorfDJ. (2009). MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol, 23:925–931.
20.
YangZ, BianC, ZhouH, HuangS, WangS, LiaoL and ZhaoRC. (2011). MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev, 20:259–267.
21.
ZaragosiLE, WdziekonskiB, BrigandKL, VillageoisP, MariB, WaldmannR, DaniC and BarbryP. (2011). Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol, 12:R64
22.
ZhangJ, TuQ, BonewaldLF, HeX, SteinG, LianJ and ChenJ. (2011). Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res, 26:1953–1963.
23.
HuangJ, ZhaoL, XingL and ChenD. (2010). MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells, 28:357–364.
24.
LiH, LiT, WangS, WeiJ, FanJ, LiJ, HanQ, LiaoL, ShaoC and ZhaoRC. (2013). miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res, 10:313–324.
25.
ZhangJF, FuWM, HeML, WangH, WangWM, YuSC, BianXW, ZhouJ, LinMC, et al. (2011). MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell, 22:3955–3961.
26.
RoushS and SlackFJ. (2008). The let-7 family of microRNAs. Trends Cell Biol, 18:505–516.
27.
Esquela-KerscherA and SlackFJ. (2006). Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer, 6:259–269.
28.
ReinhartBJ, SlackFJ, BassonM, PasquinelliAE, BettingerJC, RougvieAE, HorvitzHR and RuvkunG. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 403:901–906.
29.
YuF, YaoH, ZhuP, ZhangX, PanQ, GongC, HuangY, HuX, SuF, LiebermanJ and SongE. (2007). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131:1109–1123.
30.
GoffLA, BoucherS, RicuperoCL, FenstermacherS, SwerdelM, ChaseLG, AdamsCC, ChesnutJ, LakshmipathyU and HartRP. (2008). Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis. Exp Hematol, 36:1354–1369.
31.
LeeYS and DuttaA. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev, 21:1025–1030.
32.
MayrC, HemannMT and BartelDP. (2007). Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science, 315:1576–1579.
33.
CaoY, SunZ, LiaoL, MengY, HanQ and ZhaoRC. (2005). Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun, 332:370–379.
34.
FergusonVL, AyersRA, BatemanTA and SimskeSJ. (2003). Bone development and age-related bone loss in male C57BL/6J mice. Bone, 33:387–398.
35.
KajkenovaO, Lecka-CzernikB, GubrijI, HauserSP, TakahashiK, ParfittAM, JilkaRL, ManolagasSC and LipschitzDA. (1997). Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res, 12:1772–1779.
36.
NuttallME and GimbleJM. (2000). Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?. Bone, 27:177–184.
37.
KolfCM, ChoE and TuanRS. (2007). Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther, 9:204.
38.
UndaleAH, WestendorfJJ, YaszemskiMJ and KhoslaS. (2009). Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc, 84:893–902.
39.
LianJB, SteinGS, van WijnenAJ, SteinJL, HassanMQ, GaurT and ZhangY. (2012). MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol, 8:212–227.
40.
HammondSM and SharplessNE. (2008). HMGA2, microRNAs, and stem cell aging. Cell, 135:1013–1016.
FuscoA and FedeleM. (2007). Roles of HMGA proteins in cancer. Nat Rev Cancer, 7:899–910.
43.
NishinoJ, KimI, ChadaK and MorrisonSJ. (2008). Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell, 135:227–239.
44.
MonzenK, ItoY, NaitoAT, KasaiH, HiroiY, HayashiD, ShiojimaI, YamazakiT, MiyazonoK, et al. (2008). A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat Cell Biol, 10:567–574.
45.
WeedonMN, LettreG, FreathyRM, LindgrenCM, VoightBF, PerryJR, ElliottKS, HackettR, GuiducciC, et al. (2007). A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Genet, 39:1245–1250.
46.
LigonAH, MooreSD, ParisiMA, MealiffeME, HarrisDJ, FergusonHL, QuadeBJ and MortonCC. (2005). Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. Am J Hum Genet, 76:340–348.
47.
MarkowskiDN, HelmkeBM, MeyerF, von AhsenI, NimzykR, NolteI and BullerdiekJ. (2011). BMP4 increases expression of HMGA2 in mesenchymal stem cells. Cytokine, 56:811–816.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
